Creative Medical Technology Holdings (CELZ) Interest Expenses (2010 - 2023)

Creative Medical Technology Holdings (CELZ) has reported Interest Expenses for 13 consecutive years, with $50.0 the latest figure, recorded in Q1 2023.

• On a quarterly basis, Interest Expenses changed N/A year-over-year to $50.0 in Q1 2023; TTM through Mar 2024 was $50.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $4.3 million, up 247.96% from the prior year.
• Interest Expenses was $50.0 for Q1 2023 at Creative Medical Technology Holdings, down from $2.4 million in the prior quarter.
• Over five years, Interest Expenses peaked at $2.4 million in Q4 2021 and troughed at $50.0 in Q1 2023.
• A 4-year average of $569507.8 and a median of $336076.0 in 2021 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses plunged 45.35% in 2020 and jumped 652.38% in 2021, its largest moves.
• Over 4 years, Interest Expenses stood at $407544.0 in 2019, then dropped by 21.64% to $319354.0 in 2020, then jumped by 652.38% to $2.4 million in 2021, then tumbled by 100.0% to $50.0 in 2023.
• The last three Interest Expenses figures came in at $50.0 (Q1 2023), $2.4 million (Q4 2021), and $1.3 million (Q3 2021), per Business Quant data.